ANL
Price
$1.61
Change
+$0.05 (+3.21%)
Updated
Aug 11, 04:55 PM (EDT)
Capitalization
57.56M
Earnings call today
LENZ
Price
$38.76
Change
+$4.08 (+11.76%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
1.11B
Interact to see
Advertisement

ANL vs LENZ

Header iconANL vs LENZ Comparison
Open Charts ANL vs LENZBanner chart's image
Adlai Nortye
Price$1.61
Change+$0.05 (+3.21%)
Volume$100
Capitalization57.56M
LENZ Therapeutics
Price$38.76
Change+$4.08 (+11.76%)
Volume$7.71K
Capitalization1.11B
ANL vs LENZ Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. LENZ commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (ANL: $1.56 vs. LENZ: $34.68)
Brand notoriety: ANL and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 74% vs. LENZ: 299%
Market capitalization -- ANL: $59.41M vs. LENZ: $1.11B
ANL [@Biotechnology] is valued at $59.41M. LENZ’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, LENZ is a better buy in the long-term than ANL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while LENZ’s TA Score has 5 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 2 bearish.
  • LENZ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANL is a better buy in the short-term than LENZ.

Price Growth

ANL (@Biotechnology) experienced а +7.59% price change this week, while LENZ (@Biotechnology) price change was +15.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($1.11B) has a higher market cap than ANL($57.6M). LENZ YTD gains are higher at: 20.125 vs. ANL (-41.904).
ANLLENZANL / LENZ
Capitalization57.6M1.11B5%
EBITDAN/A-61.87M-
Gain YTD-41.90420.125-208%
P/E RatioN/A48.03-
RevenueN/A5M-
Total CashN/A210M-
Total DebtN/A1.05M-
TECHNICAL ANALYSIS
Technical Analysis
ANLLENZ
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIAMX28.570.24
+0.85%
Diamond Hill Long-Short Inv
SBSPX49.570.39
+0.79%
Franklin S&P 500 Index A
NIECX18.370.08
+0.44%
BNY Mellon International Equity C
PSEPX19.410.06
+0.31%
1789 Growth and Income P
JNGTX74.220.12
+0.16%
Janus Henderson Glb Tech and Innovt D

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and NVCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and NVCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
+0.65%
NVCT - ANL
22%
Poorly correlated
-2.76%
JAZZ - ANL
21%
Poorly correlated
-0.70%
LENZ - ANL
21%
Poorly correlated
+7.97%
RIGL - ANL
20%
Poorly correlated
+4.14%
FTRE - ANL
20%
Poorly correlated
-9.12%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with ZYME. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+7.97%
ZYME - LENZ
46%
Loosely correlated
-1.15%
BEAM - LENZ
45%
Loosely correlated
-1.34%
CRNX - LENZ
44%
Loosely correlated
-3.69%
XNCR - LENZ
44%
Loosely correlated
-1.23%
ETNB - LENZ
43%
Loosely correlated
+1.55%
More